• Moxidectin (SKU B3611): Reliable Macrocyclic Lactone Anthelm

  2026-06-11

  This article offers practical, evidence-based guidance for biomedical researchers and lab technicians evaluating Moxidectin (SKU B3611) in cell viability and antifungal synergy assays. Scenario-driven Q&A blocks address common experimental challenges, focusing on reproducibility, solubility, and cross-domain innovation. Leverage insights on APExBIO's Moxidectin for robust experimental design and dependable results.

• Dasatinib (BMS-354825): Applied Kinase Inhibition Workflows

  2026-06-10

  Dasatinib (BMS-354825) empowers researchers to dissect Src and Bcr-Abl kinase signaling with nanomolar precision, supporting both solid and hematologic cancer models. This article delivers actionable protocols, troubleshooting strategies, and practical insights tailored for advanced studies in kinase-driven malignancies.

• Imipramine in Research: Tricyclic Antidepressant Drives Auto

  2026-06-10

  Imipramine stands out as a tricyclic antidepressant with unique utility in cancer and neuroscience research, notably for its ability to modulate autophagy and apoptosis. This article details validated workflows, protocol parameters, and troubleshooting strategies to maximize its impact in glioma, leukemia, and neuroprotection studies.

• AG-490 (Tyrphostin B42): Advanced Modulation of JAK2/STAT6 i

  2026-06-09

  Explore the unique power of AG-490 (Tyrphostin B42) in dissecting JAK2/STAT6-driven immunopathology, with a focus on exosome-mediated macrophage polarization. This guide offers deep insights for researchers seeking advanced control over cancer microenvironment assays.

• Bispecific Anti-M1R/B6R Antibodies Advance Orthopoxvirus The

  2026-06-09

  This study presents the comprehensive characterization of monoclonal antibodies targeting the dominant immunogens M1R and B6R of mpox virus (MPXV), leading to the rational design of bispecific antibodies with superior antiviral efficacy. These findings offer a framework for developing broad-spectrum antibody therapeutics against mpox and related orthopoxvirus infections.

• Tamoxifen (SKU B5965): Resolving Core Lab Assay Challenges

  2026-06-08

  This article addresses common laboratory challenges in cell viability, proliferation, and CreER-mediated gene knockout assays, showing how Tamoxifen (SKU B5965) from APExBIO delivers reproducible, data-driven solutions. Scenario-based Q&A blocks guide best practices, protocol optimization, and vendor selection for rigorous biomedical research.

• Molnupiravir Protects Mice from Lethal Bourbon Virus Infecti

  2026-06-08

  This study demonstrates that molnupiravir, a broad-spectrum antiviral, significantly inhibits Bourbon virus replication and disease in a lethal mouse model. The findings highlight molnupiravir's potential as a therapeutic candidate for emerging tick-borne RNA virus infections lacking approved treatments.

• Ether Lipid Biosynthesis in B Cells Boosts Antibody Response

  2026-06-07

  Cho et al. (2026) reveal that B cell-intrinsic expression of the PexRAP enzyme, a key intermediary in ether lipid biosynthesis, is crucial for robust antibody responses and germinal center formation. These findings link lipid metabolic pathways directly to humoral immunity, offering new mechanistic insights into the metabolic regulation of B cell function.

• Leptin (116-130), amide, mouse: Novel Pathways in Immunometa

  2026-06-06

  Explore the pleiotropic effects and translational promise of Leptin (116-130), amide, mouse, an adipocyte-derived hormone fragment. This article uniquely bridges immunometabolic signaling and inflammasome research, offering advanced insights for obesity and diabetes studies.

• Fluorescein Tyramide: Amplifying Sensitivity in IHC & ISH As

  2026-06-05

  Fluorescein Tyramide elevates signal detection in low-abundance target assays through robust tyramide signal amplification, transforming workflows in immunohistochemistry and in situ hybridization. Drawing on recent oxytocin pathway research and peer-validated protocols, this article delivers hands-on guidance to optimize sensitivity, troubleshoot artifacts, and achieve reproducible results.

• Dasatinib (BMS-354825): Applied Protocols for Kinase-Driven

  2026-06-05

  Dasatinib (BMS-354825) empowers cancer researchers to dissect Src and Bcr-Abl kinase signaling with exceptional potency and flexibility. This guide delivers actionable, evidence-driven workflows and troubleshooting strategies for advanced studies in EMT, cancer stemness, and metastatic processes.

• AMPK’s Dual Role in Autophagy Revealed: Insights into ULK1 R

  2026-06-04

  This study overturns the prevailing model by showing that AMPK suppresses, rather than induces, autophagy via inhibition of ULK1. The findings refine our understanding of energy stress responses and provide a more nuanced framework for targeting autophagy in disease models.

• Actinomycin D (A4448): Benchmark Transcriptional Inhibitor

  2026-06-04

  Actinomycin D (ActD) is a potent transcriptional inhibitor widely used in cancer research and molecular biology. Its ability to intercalate DNA and block RNA polymerase enables precise dissection of gene regulation and apoptosis induction. This article summarizes mechanisms, evidence, and protocol best practices for reliable deployment in transcriptional stress and DNA damage response assays.

• Remdesivir (GS-5734): Strategic Insights for Translational V

  2026-06-03

  This thought-leadership article provides translational researchers with a mechanistic and strategic perspective on Remdesivir (GS-5734), highlighting its validated antiviral mechanism, experimental benchmarks, and guidance for advancing coronavirus and Ebola virus antiviral research. Integrating recent comparative findings and expert workflows, the piece advances beyond standard product pages to address evolving challenges in RNA virus translational science.

• KN-62: Precision CaMKII Inhibition in Calcium Signaling Assa

  2026-06-03

  KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, is a benchmark tool for dissecting CaMKII-mediated calcium signaling and cell cycle control. This article equips researchers with evidence-backed experimental workflows, advanced applications, and troubleshooting guidance to maximize the selective power of KN-62 in metabolic, cancer, and secretion studies.

16054 records 2/1071 page Previous Next 12345 下5页 Last page